Review the side-effects of Thrombin Topical Bovine Origin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.
PARSIPPANY, NJ--(Marketwired - May 9, 2013) - The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for RECOTHROM®, Thrombin ...
February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...
This medication is hematologic agent, prescribed for hemostasis and for temporary control of moderately to severely bleeding wounds.
Thrombin [bovine origin] 5000 IU, 20000 IU; per vial; pwd for topical use after reconstitution; preservative-free. Thrombin-JMI requires no intermediate physiological agent for its action. It ...
Please provide your email address to receive an email when new articles are posted on . Based upon increased concerns about the infectious and noninfectious risks of blood transfusions, physicians are ...
First and Only Bovine-Free Stand-Alone Topical Thrombin Approved by FDA NEW YORK -- OMRIX Biopharmaceuticals, a commercial-stage biopharmaceutical company that develops and markets biosurgical and ...
The FDA Thursday approved ZymoGenetics Inc.'s Recothrom Thrombin, the first and only recombinant, plasma-free thrombin for use as a topical hemostat. News of the approval sent shares of ZymoGenetics ...
PARSIPPANY, NJ and LEIDEN, THE NETHERLANDS and SEATTLE, WA--(Marketwired - Aug 5, 2013) - The Medicines Company (NASDAQ: MDCO) announced the results of the pivotal Phase III clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback